Structure Therapeutics Inc. - GPCR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Chief Development Officer | A | A | 59,073.0 | 0.0 | 0.0 | 59,073.0 | View | |
| Mar 23, 2026 | Chief Development Officer | A | A | 47,706.0 | 0.0 | 0.0 | 155,187.0 | View | |
| Mar 23, 2026 | CHIEF FINANCIAL OFFICER | A | A | 128,892.0 | 0.0 | 0.0 | 128,892.0 | View | |
| Mar 23, 2026 | CHIEF FINANCIAL OFFICER | A | A | 104,085.0 | 0.0 | 0.0 | 1,401,656.0 | View | |
| Mar 23, 2026 | CHIEF SCIENTIFIC OFFICER | A | A | 53,703.0 | 0.0 | 0.0 | 53,703.0 | View | |
| Mar 23, 2026 | CHIEF SCIENTIFIC OFFICER | A | A | 43,368.0 | 0.0 | 0.0 | 228,960.0 | View | |
| Mar 23, 2026 | CHIEF TECHNOLOGY OFFICER | A | A | 40,278.0 | 0.0 | 0.0 | 40,278.0 | View | |
| Mar 23, 2026 | CHIEF TECHNOLOGY OFFICER | A | A | 32,526.0 | 0.0 | 0.0 | 139,917.0 | View | |
| Mar 23, 2026 | CHIEF MEDICAL OFFICER | A | A | 93,984.0 | 0.0 | 0.0 | 93,984.0 | View | |
| Mar 23, 2026 | CHIEF MEDICAL OFFICER | A | A | 75,897.0 | 0.0 | 0.0 | 280,878.0 | View | |
| Mar 23, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 322,230.0 | 0.0 | 0.0 | 322,230.0 | View | |
| Mar 23, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 260,217.0 | 0.0 | 0.0 | 1,401,593.0 | View | |
| Mar 05, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 824.0 | 0.0 | 0.0 | 1,824.0 | View | |
| Mar 05, 2026 | CHIEF EXECUTIVE OFFICER | F | D | 53,454.0 | 20.99 | 1,121,999.46 | 1,141,376.0 | View | |
| Mar 05, 2026 | CHIEF TECHNOLOGY OFFICER | F | D | 11,313.0 | 20.99 | 237,459.87 | 107,391.0 | View | |
| Mar 05, 2026 | CHIEF FINANCIAL OFFICER | F | D | 22,305.0 | 20.99 | 468,181.95 | 1,297,571.0 | View | |
| Mar 05, 2026 | Chief Development Officer | A | A | 237.0 | 0.0 | 0.0 | 462.0 | View | |
| Mar 05, 2026 | Chief Development Officer | A | A | 225.0 | 0.0 | 0.0 | 225.0 | View | |
| Mar 05, 2026 | Chief Development Officer | F | D | 4,836.0 | 20.99 | 101,507.64 | 107,481.0 | View | |
| Mar 05, 2026 | CHIEF SCIENTIFIC OFFICER | F | D | 18,735.0 | 20.99 | 393,247.65 | 185,592.0 | View | |
| Mar 05, 2026 | CHIEF MEDICAL OFFICER | F | D | 11,826.0 | 20.99 | 248,227.74 | 204,981.0 | View | |
| Jan 20, 2026 | — | S | D | 230.0 | 85.04 | 19,559.2 | 48,256.0 | View | |
| Jan 20, 2026 | — | S | D | 6,498.0 | 84.22 | 547,261.56 | 48,486.0 | View | |
| Jan 20, 2026 | — | S | D | 3,880.0 | 83.35 | 323,398.0 | 54,984.0 | View | |
| Jan 20, 2026 | — | S | D | 5,477.0 | 82.1 | 449,661.7 | 58,864.0 | View | |
| Jan 20, 2026 | — | S | D | 20.0 | 85.04 | 1,700.8 | 4,103.0 | View | |
| Jan 20, 2026 | — | S | D | 552.0 | 84.22 | 46,489.44 | 4,123.0 | View | |
| Jan 20, 2026 | — | S | D | 330.0 | 83.35 | 27,505.5 | 4,675.0 | View | |
| Jan 20, 2026 | — | S | D | 465.0 | 82.1 | 38,176.5 | 5,005.0 | View | |
| Dec 10, 2025 | — | S | D | 15,535.0 | 61.45 | 954,625.75 | 0.0 | View | |
| Dec 10, 2025 | — | S | D | 16,635.0 | 61.05 | 1,015,566.75 | 15,535.0 | View | |
| Dec 10, 2025 | — | S | D | 5,589.0 | 94.61 | 528,775.29 | 32,170.0 | View | |
| Dec 10, 2025 | — | S | D | 2,159.0 | 94.0 | 202,946.0 | 37,759.0 | View | |
| Dec 10, 2025 | — | S | D | 8,337.0 | 92.52 | 771,339.24 | 39,918.0 | View | |
| Dec 10, 2025 | — | S | D | 1,320.0 | 61.45 | 81,114.0 | 1.0 | View | |
| Dec 10, 2025 | — | S | D | 1,414.0 | 61.05 | 86,324.7 | 1,321.0 | View | |
| Dec 10, 2025 | — | S | D | 475.0 | 94.61 | 44,939.75 | 2,735.0 | View | |
| Dec 10, 2025 | — | S | D | 183.0 | 94.0 | 17,202.0 | 3,210.0 | View | |
| Dec 10, 2025 | — | S | D | 709.0 | 92.52 | 65,596.68 | 3,393.0 | View |